Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications
Longitudinal multi-platform profiling reveals temporal dynamics of HER2, TROP2, PD-L1 and tumor-infiltrating lymphocytes in triple-negative breast cancer.
Journal: medRxiv : the preprint server for health sciences
Published: June 05, 2026
TROP2-directed antibody-drug conjugates: new first-line treatment for all patients with advanced triple-negative breast cancer?
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: June 01, 2026
Tumor-Associated Platelets Suppress T-cell Function and Promote Immune Evasion in TNBC via the P-selectin/P-selectin Glycoprotein Ligand 1 Pathway.
Journal: Cancer research communications
Published: May 19, 2026
SACI-IO HR+: a randomized phase II trial of sacituzumab govitecan with or without pembrolizumab in patients with metastatic hormone receptor-positive/HER2-negative breast cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: March 20, 2026
SACI-IO HR+: A randomized phase II trial of sacituzumab govitecan with or without pembrolizumab in patients with metastatic hormone receptor-positive/HER2-negative breast cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: March 20, 2026
Association between self-reported breast cancer knowledge and clinical trial participation in patients with triple-negative breast cancer.
Journal: Breast cancer research and treatment
Published: November 23, 2025
Tumor genomics in patients younger than 40 years of age with metastatic breast cancer.
Journal: NPJ precision oncology
Published: October 08, 2025
Quantitative HER2 tissue and plasma profiling predicts the activity of trastuzumab deruxtecan for breast cancer.
Journal: NPJ precision oncology
Published: September 06, 2025
The landscape of the intestinal microbiome among patients with newly diagnosed invasive breast cancer and ductal carcinoma in situ (DCIS).
Journal: NPJ breast cancer
Published: August 18, 2025
Management of Metastatic Hormone Receptor-Positive Breast Cancer Beyond CDK4/6 Inhibitors.
Journal: Current oncology reports
Published: May 09, 2025
Last Updated: 09/26/2026